Deprenyl compounds for treatment of glaucoma
    1.
    发明授权
    Deprenyl compounds for treatment of glaucoma 失效
    用于治疗青光眼的Dep yl yl啶化合物

    公开(公告)号:US06455590B1

    公开(公告)日:2002-09-24

    申请号:US09374455

    申请日:1999-08-13

    申请人: William G. Tatton

    发明人: William G. Tatton

    IPC分类号: A61K31135

    摘要: Methods and kits for treament of glaucoma are disclosed. In general, the methods of the invention include administering a therapeutically effective amount of a deprenyl compound to a subject such that the subject is treated for glaucoma.

    摘要翻译: 公开了治疗青光眼的方法和试剂盒。 通常,本发明的方法包括向受试者施用治疗有效量的去肾上腺素化合物,使得受试者被治疗青光眼。

    Methods for increasing schwann cell survival
    4.
    发明授权
    Methods for increasing schwann cell survival 失效
    增加雪旺细胞存活的方法

    公开(公告)号:US06417160B1

    公开(公告)日:2002-07-09

    申请号:US09170460

    申请日:1998-10-13

    IPC分类号: A61K3800

    CPC分类号: A61K31/137 A61K31/195

    摘要: Methods for increasing Schwann cell survival are disclosed. The methods of the invention are useful for the treatment of conditions such as peripheral neuropathies, including diabetic neuropathies.

    摘要翻译: 公开了增加雪旺氏细胞存活的方法。 本发明的方法可用于治疗诸如周围神经病之类的疾病,包括糖尿病性神经病。

    Deprenyl compounds for treatment of glaucoma
    5.
    发明授权
    Deprenyl compounds for treatment of glaucoma 失效
    用于治疗青光眼的Dep yl yl啶化合物

    公开(公告)号:US5783606A

    公开(公告)日:1998-07-21

    申请号:US598845

    申请日:1996-02-09

    申请人: William G. Tatton

    发明人: William G. Tatton

    IPC分类号: A61K31/135 A61K31/137

    摘要: Methods and kits for treatment of glaucoma are disclosed. In general, the methods of the invention include administering a therapeutically effective amount of a deprenyl compound to a subject such that the subject is treated for glaucoma.

    摘要翻译: 公开了用于治疗青光眼的方法和试剂盒。 通常,本发明的方法包括向受试者施用治疗有效量的去肾上腺素化合物,使得受试者被治疗青光眼。